PURIFICATION AND PROPERTIES OF DIHYDROFOLATE REDUCTASE FROM EHRLICH ASCITES CARCINOMA CELLS
- PMID: 14337699
- DOI: 10.1021/bi00881a007
PURIFICATION AND PROPERTIES OF DIHYDROFOLATE REDUCTASE FROM EHRLICH ASCITES CARCINOMA CELLS
Similar articles
-
INTERACTION OF ORGANIC MERCURIAL COMPOUNDS WITH DIHYDROFOLATE REDUCTASE FROM EHRLICH ASCITES CARCINOMA CELLS.Biochemistry. 1965 May;4:847-53. doi: 10.1021/bi00881a008. Biochemistry. 1965. PMID: 14337700 No abstract available.
-
STUDIES ON THE INHIBITION OF DIHYDROFOLATE REDUCTASE BY THE FOLATE ANTAGONISTS.J Biol Chem. 1964 Feb;239:479-85. J Biol Chem. 1964. PMID: 14169148 No abstract available.
-
INHIBITION OF INOSINE 5'-PHOSPHATE DEHYDROGENASE FROM EHRLICH ASCITES-TUMOUR CELLS BY 6-THIONINOSINE 5'-PHOSPHATE.Biochem J. 1963 Oct;89(1):167-72. doi: 10.1042/bj0890167. Biochem J. 1963. PMID: 14097359 Free PMC article. No abstract available.
-
Role of the cellular oxidation-reduction state in methotrexate binding to dihydrofolate reductase and dissociation induced by reduced folates.Cancer Res. 1984 Jun;44(6):2325-30. Cancer Res. 1984. PMID: 6609765
-
PURIFICATION AND PROPERTIES OF DIHYDROFOLATE REDUCTASE OF SHEEP LIVER.Biochim Biophys Acta. 1964 Jun 1;85:360-76. doi: 10.1016/0926-6569(64)90300-1. Biochim Biophys Acta. 1964. PMID: 14194852 No abstract available.
Cited by
-
Experimental intraocular malignancy: the effect of intracameral perfusion.Trans Am Ophthalmol Soc. 1979;77:63-79. Trans Am Ophthalmol Soc. 1979. PMID: 232585 Free PMC article.
-
Drug-induced megaloblastic anemia.Dig Dis Sci. 2005 Oct;50(10):1778-9. doi: 10.1007/s10620-005-2936-7. Dig Dis Sci. 2005. PMID: 16187172 No abstract available.
-
The effect of methotrexate on folate metabolism in the rat.Br J Cancer. 1980 May;41(5):816-20. doi: 10.1038/bjc.1980.146. Br J Cancer. 1980. PMID: 7426306 Free PMC article.
-
Antineoplastic activity of lipid-soluble dialkyl esters of methotrexate.Experientia. 1973 Sep 15;29(9):1104-5. doi: 10.1007/BF01946745. Experientia. 1973. PMID: 4744861 No abstract available.
-
Cytotoxicity of trimetrexate against antifolate-resistant human T-cell leukemia cell lines developed in oxidized or reduced folate.Jpn J Cancer Res. 1997 Sep;88(9):900-6. doi: 10.1111/j.1349-7006.1997.tb00467.x. Jpn J Cancer Res. 1997. PMID: 9369939 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Miscellaneous